The S&P Pharma Dose
Featured Podcast
-
Listen:S&P Pharma Dose - Episode 34: More Color on PPD’s Rating After IPO
-
Listen:The S&P Pharma Dose - Pharmacy Benefit Manager Industry In 2020: Less Regulatory Overhang, Expect More Consolidations
-
Listen:The S&P Pharma Dose – Episode 32: Pfizer Finds Home For Upjohn, Though Lessened Diversity Results In Lower Rating